Erik L. Meredith
Novartis (United States)(US)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Glaucoma and retinal disorders, Bioactive Compounds and Antitumor Agents, Asymmetric Synthesis and Catalysis, Retinal Diseases and Treatments
Most-Cited Works
- → Design and Synthesis of Potent Sensitizers of Gram-Negative Bacteria Based on a Cholic Acid Scaffolding(1998)123 cited
- → Synthesis of resveratrol using a direct decarbonylative Heck approach from resorcylic acid(2003)83 cited
- → Total Synthesis of (+)-Geldanamycin and (−)-o-Quinogeldanamycin: Asymmetric Glycolate Aldol Reactions and Biological Evaluation(2003)81 cited
- → Anti-Selective Glycolate Aldol Additions with an Oxapyrone Boron Enolate(2000)77 cited
- → Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation(2014)73 cited
- → Total Synthesis of (+)-Geldanamycin and (−)-o-Quinogeldanamycin with Use of Asymmetric Anti- and Syn-Glycolate Aldol Reactions(2002)69 cited
- → A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase(2009)58 cited
- → Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors(2010)53 cited
- → Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors(2013)46 cited
- → Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D(2010)41 cited